Number 3: Part 2 of our series diving into the Association for Accessible Medicines' (AAM) latest report discusses that while ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $24.58, a high ...

Healthy adults who contracted COVID-19 had subtle but measurable declines in memory and cognitive performance lasting up to a ...

UCSF is recognized globally for innovative treatments, advanced technology and pioneering research applied to patient care ... From primary care to the most complex conditions, our clinical programs ...

Updates on the development of Humanetics Corporation’s (Humanetics) new drug candidate, BIO 300, were presented at the 2024 Military Health System Research Symposium (MHSRS), held August 26-29th in ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the company's commitment to make at least two million doses of ...

Keywords: Skin Aging, clinical applications, aging genetics Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as ...

The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

Cerebral adrenoleukodystrophy (CALD) is a rare progressive, genetic brain disease that primarily presents in young boys, causing loss of neurological function and ultimately leading to early death.

Clinical trials sponsored by Big Pharma enrolled eight times as many patients as U.S.-government trials did between 2018 and ...